A structured medical workup begins with continued gluten intake for several weeks, proceeds to a tissue transglutaminase IgA antibody blood draw, and confirms positive serology through an upper endoscopy with duodenal biopsy. Skipping the gluten phase or skipping the biopsy can quietly produce a wrong answer, leaving real intestinal damage undiagnosed.
This guide walks through the celiac disease diagnosis process from first blood draw to final biopsy reading, so you know what each step demands of you.
Why a Formal Diagnosis Matters Before Changing Your Diet
About 1% of the global population lives with celiac disease, an autoimmune reaction in which gluten triggers the immune system to attack the lining of the small intestine. That lining contains tiny finger-shaped projections called villi, and when they erode, nutrient absorption collapses. Left alone, the condition drives iron deficiency, osteoporosis, infertility, and a higher risk of certain cancers.
Cutting gluten on your own feels like a shortcut to feeling better, but it actually sabotages the test. Once gluten disappears from the diet, the antibodies that signal celiac disease gradually fade, and the gut lining begins to rebuild. A blood test run at that point often returns a clean negative even though the disease is still very much active.
A confirmed diagnosis also unlocks long-term monitoring, DEXA bone scans, vaccination reviews, and access to a registered dietitian who specializes in celiac management. That guidance aligns with recommendations from the National Institutes of Health and the American Gastroenterological Association, which both warn against starting a gluten-free diet before completing the full workup.
Following those guidelines, the next step for most patients is loading gluten back up so the body has something to react to.
Avoid gluten elimination before testing. Even two weeks off gluten can drop antibody levels enough to produce a false-negative result.
The Gluten Challenge: Eating Gluten Before the Test
The single biggest variable you control in celiac testing is gluten consumption in the weeks before blood work. Antibody levels rise and fall with gluten intake, so the immune system needs active exposure to generate a measurable signal.
Standard Daily Intake for Adults
Most guidelines call for at least two servings of gluten per day, every day, for six to eight weeks before screening. A serving looks like a slice of regular bread, a half-cup of cooked pasta, or a few standard crackers. Both the Mayo Clinic and the Celiac Disease Foundation publish this range, and gastroenterologists treat it as the default protocol for adults with no recent gluten exposure.
Shorter Protocols and Pediatric Adjustments
Some patients simply cannot tolerate a full eight-week challenge because vomiting, severe fatigue, or intense cramping sets in within days. A gastroenterologist can shorten the gluten challenge to two to four weeks, especially in children, where the Celiac Disease Foundation notes that shorter supervised challenges can still produce reliable serology. Children with clear symptoms and very high antibody titers can sometimes be diagnosed faster under pediatric guidance, but the gluten exposure still has to happen.
When Gluten Has Already Been Removed
Months or years without gluten may require a supervised oral gluten challenge, which can re-expose the immune system long enough to restore detectable antibodies. This typically means eating roughly 3 grams of gluten daily for two to eight weeks, with blood draws at intervals to track whether antibodies reappear. Anyone with severe reactions should never self-administer this kind of challenge, since it requires monitoring by a clinician.
Once the challenge is underway, blood tests become the first window into what that gluten exposure is doing.
First-Line Blood Tests and What Each Marker Reveals
Once gluten intake is confirmed, the next step is a blood draw. Celiac screening is serological, meaning the lab looks for antibodies your immune system produces in response to gluten. No single test tells the whole story, so clinicians usually order a panel.
| Test | What It Measures | Role in Diagnosis |
|---|---|---|
| Tissue transglutaminase IgA (tTG-IgA) | Antibody against an intestinal enzyme | Standard first-line screen with roughly 95% sensitivity |
| Total IgA | Overall IgA antibody level | Detects IgA deficiency that causes false negatives |
| Endomysial antibody (EMA) | Antibody targeting connective tissue | Confirmatory test when tTG is borderline |
| Deamidated gliadin peptide (DGP) IgG/IgA | Antibody against modified gluten fragments | Useful for IgA-deficient patients or young children |
Why Total IgA Always Travels with tTG
About 2 to 3 percent of patients with celiac disease also have selective IgA deficiency, a condition in which the body produces almost no IgA antibodies at all. If the lab only runs tTG-IgA, the result comes back falsely negative because the underlying IgA is too low to register. That is why every reputable celiac panel pairs tTG-IgA with a total IgA measurement. When total IgA is low, the lab reroutes to IgG-based tests like DGP-IgG.
High-Titer Results and the ESPGHAN Shortcut
When tTG-IgA comes back more than ten times the upper limit of normal and a second antibody test, usually EMA, confirms the finding, the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines allow some children to skip the biopsy entirely. This pathway applies mainly to symptomatic children with very clear serology, and it is not standard practice for adults, who almost always proceed to endoscopic confirmation.
Upper Endoscopy and Biopsy: Confirming Intestinal Damage
A positive or strongly suggestive blood test moves you to the next stage, an upper endoscopy with duodenal biopsy. This step matters because serology alone cannot measure the physical damage celiac disease leaves behind.
What the Procedure Involves
An upper endoscopy takes 15 to 30 minutes under sedation. A thin tube with a camera passes through the mouth, down the esophagus, and into the duodenum, the first part of the small intestine. The gastroenterologist collects four to six tissue samples from different locations, since celiac damage can be patchy. Most facilities discharge you the same day, with mild throat soreness and bloating that fade within hours.
Reading the Biopsy: The Marsh Classification
A pathologist grades each sample using the Marsh scale, which ranges from Marsh 0 (normal) to Marsh 3c (complete villous flattening). Intermediate stages describe increasing inflammation and structural damage. A Marsh 3 reading, partial or total villous atrophy, is the classic celiac finding that confirms the diagnosis.
| Marsh Stage | Histological Finding | Interpretation |
|---|---|---|
| Marsh 0 | Normal mucosa | No active celiac damage |
| Marsh 1 | Increased intraepithelial lymphocytes | Early or mild inflammation |
| Marsh 2 | Crypt hyperplasia plus lymphocytic infiltrate | Progressive damage |
| Marsh 3a–3c | Partial to total villous atrophy | Diagnostic of celiac disease |
The biopsy is also where clinicians rule out look-alike conditions. Crohn’s disease, eosinophilic gastroenteritis, and certain infections can mimic celiac symptoms, and only direct tissue inspection separates them. Skipping this step on the basis of blood work alone is one of the most common diagnostic shortcuts that turns out to be wrong.
Even with biopsies in hand, antibody patterns sometimes leave room for doubt that only genetics can resolve.
Genetic Testing Versus Antibody Testing: Choosing the Right Path
Genetic testing plays a different role than serology. Instead of measuring current damage, it identifies the inherited predisposition that makes celiac disease possible in the first place.
HLA-DQ2 and HLA-DQ8: The Susceptibility Genes
More than 95 percent of celiac patients carry HLA-DQ2, and most of the remainder carry HLA-DQ8, making these the dominant genetic markers of susceptibility. A simple cheek swab or blood sample looks for these specific gene variants. The result tells you whether you carry the genetic blueprint for celiac disease, which roughly 30 to 40 percent of the general population does.
What a Negative Result Means
Because nearly every celiac patient has one of these markers, a negative genetic test effectively rules out the disease. This makes HLA typing especially valuable when serology is ambiguous, when a patient has already started a gluten-free diet, or when a clinician wants to investigate persistent symptoms without committing to a full gluten challenge. A negative finding lets everyone move on to other causes.
What a Positive Result Does Not Mean
A positive HLA-DQ2 or DQ8 result only confirms susceptibility. Roughly one-third of carriers never develop celiac disease, and many never will. Carrying the genes is a prerequisite, not a diagnosis. Genetic testing is most useful for family screening of first-degree relatives, evaluating borderline cases, and clarifying the picture when antibody results are confusing.
Interpreting Results, Avoiding False Negatives, and Planning Next Steps
Test results in celiac disease are not always binary. Knowing why a result might mislead you is part of getting a reliable answer.
Common Causes of False-Negative Serology
Several factors can flatten antibody levels even when celiac disease is present. The most common cause is recent gluten avoidance. IgA deficiency, early-stage disease with minimal antibody production, and immunosuppressive medications like corticosteroids or biologics can also suppress the signal. Children under two sometimes produce weaker antibody responses, which is why DGP-IgG is added to their panels.
At-Home Antibody Kits and Their Limits
Several companies sell finger-prick celiac antibody tests for home use. These kits can flag elevated tTG antibodies and suggest that celiac disease is likely, but they cannot replace a clinical workup. Without total IgA measurement, EMA confirmation, and biopsy data, the result is incomplete. Treat an at-home positive as a reason to see a gastroenterologist, not as a final answer.
After a Confirmed Diagnosis
A biopsy-confirmed diagnosis triggers lifelong gluten avoidance, usually with guidance from a dietitian who specializes in celiac disease and follow-up serology to confirm mucosal healing. Follow-up blood work every six to twelve months tracks whether tTG-IgA returns to normal, a sign the gut is healing. Clinicians also screen for related autoimmune conditions like thyroid disease and type 1 diabetes, and check bone density if malabsorption has been prolonged.
Persistent symptoms despite strict adherence call for re-evaluation, sometimes for refractory celiac disease or hidden gluten exposure in medications, sauces, or processed foods.
If symptoms continue after six months on a strict gluten-free diet, ask your gastroenterologist about repeat endoscopy, refractory disease workup, and a dietitian review of hidden gluten sources.
The Bottom Line
Reliable celiac testing is a sequence: keep eating gluten, run a tTG-IgA blood panel with total IgA, and confirm any positive result with a duodenal biopsy graded by the Marsh classification. Each step depends on the one before it, and skipping any of them risks missing a diagnosis that carries lifelong consequences.
When the workup is done properly, you walk away with a clear answer, a roadmap for healing, and access to the medical follow-up that protects your long-term health.
FAQ
What blood tests are used to screen for celiac disease?
The tissue transglutaminase IgA (tTG-IgA) test is the standard first-line screen, paired with a total IgA measurement to detect IgA deficiency. EMA and DGP tests are added when results are unclear or when IgA is low.
Do you need to eat gluten before a celiac test?
Yes. Antibody levels depend on active gluten exposure, so eating gluten daily for at least six to eight weeks before blood work is essential for accurate serology.
How long must you consume gluten before testing?
Most adults need at least two daily servings of gluten for six to eight weeks. Children and patients with severe reactions can sometimes use shorter, supervised protocols.
Can you test negative for celiac disease and still have it?
Yes. False negatives occur when gluten has been removed from the diet, when IgA is deficient, or when the disease is in an early stage. A gastroenterologist can order additional serology or genetic testing to clarify ambiguous results.
Is a biopsy always required to confirm celiac disease?
An upper endoscopy with duodenal biopsy is recommended after positive or borderline serology in adults, and in many pediatric cases. Some children with very high tTG-IgA titers and confirmed EMA may skip biopsy under ESPGHAN guidelines.
Is genetic testing useful for celiac disease?
Genetic testing for HLA-DQ2 and HLA-DQ8 has strong negative predictive value. A negative result rules out celiac disease, while a positive result confirms susceptibility but does not diagnose active disease.
